BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

541096

BPLPHARMA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Bharat Parenterals Limited Share Price Update

As of the latest trading session, Bharat Parenterals Limited share price is currently at ₹ 959, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 940.00 and ₹ 959.00. Over the past year, Bharat Parenterals Limited has achieved a return of -44.70 %. In the last month alone, the return has been -6.61 %. Read More...

Bharat Parenterals Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    558.10

  • P/E Ratio (TTM)

    23.81

  • Beta

    0.53

  • Book Value / share

    548.29

  • Return on equity

    11.16%

  • EPS (TTM)

    39.52

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    6.50

info icon alternate text

Bharat Parenterals Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 67.34
Operating Expense 62.26
Net Profit 6.50
Net Profit Margin (%) 9.65
Earnings Per Share (EPS) 8.30
EBITDA 12.13
Effective Tax Rate (%) 26.71
Particulars SEP 2024 (Values in Cr)
Revenue 64.45
Operating Expense 61.42
Net Profit 5.49
Net Profit Margin (%) 8.51
Earnings Per Share (EPS) 7.90
EBITDA 10.26
Effective Tax Rate (%) 28.04
Particulars JUN 2024 (Values in Cr)
Revenue 92.06
Operating Expense 79.70
Net Profit 12.18
Net Profit Margin (%) 13.23
Earnings Per Share (EPS) 20.26
EBITDA 18.89
Effective Tax Rate (%) 25.09
Particulars MAR 2024 (Values in Cr)
Revenue 65.64
Operating Expense 64.60
Net Profit 3.07
Net Profit Margin (%) 4.67
Earnings Per Share (EPS) 5.15
EBITDA 6.98
Effective Tax Rate (%) 28.27
Particulars DEC 2023 (Values in Cr)
Revenue 58.80
Operating Expense 54.30
Net Profit 5.07
Net Profit Margin (%) 8.62
Earnings Per Share (EPS) 8.65
EBITDA 9.18
Effective Tax Rate (%) 26.52
Particulars MAR 2024 (Values in Cr)
Revenue 254.16
Operating Expense 235.32
Net Profit 22.59
Net Profit Margin (%) 8.88
Earnings Per Share (EPS) 38.81
EBITDA 40.39
Effective Tax Rate (%) 26.65
Particulars MAR 2023 (Values in Cr)
Revenue 217.98
Operating Expense 204.65
Net Profit 24.34
Net Profit Margin (%) 11.16
Earnings Per Share (EPS) 42.40
EBITDA 40.21
Effective Tax Rate (%) 24.33
Particulars MAR 2022 (Values in Cr)
Revenue 212.01
Operating Expense 191.42
Net Profit 21.30
Net Profit Margin (%) 10.04
Earnings Per Share (EPS) 37.11
EBITDA 36.00
Effective Tax Rate (%) 24.92
Particulars MAR 2021 (Values in Cr)
Revenue 203.67
Operating Expense 185.32
Net Profit 20.21
Net Profit Margin (%) 9.92
Earnings Per Share (EPS) 35.27
EBITDA 33.44
Effective Tax Rate (%) 25.20
Particulars MAR 2020 (Values in Cr)
Revenue 226.33
Operating Expense 202.86
Net Profit 26.30
Net Profit Margin (%) 11.62
Earnings Per Share (EPS) 45.90
EBITDA 41.69
Effective Tax Rate (%) 24.74
Particulars MAR 2024 (Values in Cr)
Book Value / Share 338.96
ROE % 5.53
ROCE % 7.71
Total Debt to Total Equity 0.55
EBITDA Margin 12.36
Particulars MAR 2023 (Values in Cr)
Book Value / Share 316.55
ROE % 9.01
ROCE % 12.50
Total Debt to Total Equity 0.19
EBITDA Margin 14.69
Particulars MAR 2022 (Values in Cr)
Book Value / Share 287.16
ROE % 13.44
ROCE % 17.10
Total Debt to Total Equity 0.10
EBITDA Margin 16.91
Particulars MAR 2021 (Values in Cr)
Book Value / Share 251.09
ROE % 15.51
ROCE % 20.16
Total Debt to Total Equity 0.05
EBITDA Margin 16.58
Particulars MAR 2020 (Values in Cr)
Book Value / Share 206.27
ROE % 22.75
ROCE % 30.74
Total Debt to Total Equity 0.03
EBITDA Margin 17.33
Particulars MAR 2024 (Values in Cr)
Book Value / Share 367.05
ROE % 11.16
ROCE % 12.94
Total Debt to Total Equity 0.32
EBITDA Margin 14.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 330.86
ROE % 11.08
ROCE % 13.60
Total Debt to Total Equity 0.17
EBITDA Margin 13.62
Particulars MAR 2022 (Values in Cr)
Book Value / Share 287.72
ROE % 13.74
ROCE % 17.51
Total Debt to Total Equity 0.09
EBITDA Margin 15.08
Particulars MAR 2021 (Values in Cr)
Book Value / Share 251.22
ROE % 15.13
ROCE % 19.72
Total Debt to Total Equity 0.05
EBITDA Margin 16.60
Particulars MAR 2020 (Values in Cr)
Book Value / Share 214.92
ROE % 23.92
ROCE % 31.60
Total Debt to Total Equity 0.03
EBITDA Margin 18.42
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 12.09
Total Assets 503.82
Total Liabilities 503.82
Total Equity 238.17
Share Outstanding 5819666
Price to Book Ratio 3.06
Return on Assets (%) 2.88
Return on Capital (%) 3.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.98
Total Assets 350.34
Total Liabilities 350.34
Total Equity 217.89
Share Outstanding 5774666
Price to Book Ratio 1.02
Return on Assets (%) 4.69
Return on Capital (%) 6.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.67
Total Assets 226.05
Total Liabilities 226.05
Total Equity 170.14
Share Outstanding 5774666
Price to Book Ratio 1.19
Return on Assets (%) 9.31
Return on Capital (%) 11.21
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.43
Total Assets 198.64
Total Liabilities 198.64
Total Equity 143.81
Share Outstanding 5729666
Price to Book Ratio 1.33
Return on Assets (%) 10.26
Return on Capital (%) 13.07
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 10.40
Total Assets 187.49
Total Liabilities 187.49
Total Equity 118.18
Share Outstanding 5729666
Price to Book Ratio 0.66
Return on Assets (%) 12.87
Return on Capital (%) 20.31
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.66
Total Assets 387.15
Total Liabilities 387.15
Total Equity 213.60
Share Outstanding 5819666
Price to Book Ratio 3.06
Return on Assets (%) 5.83
Return on Capital (%) 7.62
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.42
Total Assets 308.02
Total Liabilities 308.02
Total Equity 191.06
Share Outstanding 5774666
Price to Book Ratio 1.02
Return on Assets (%) 7.90
Return on Capital (%) 10.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.60
Total Assets 218.00
Total Liabilities 218.00
Total Equity 166.15
Share Outstanding 5774666
Price to Book Ratio 1.19
Return on Assets (%) 9.77
Return on Capital (%) 11.76
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.15
Total Assets 196.23
Total Liabilities 196.23
Total Equity 143.94
Share Outstanding 5729666
Price to Book Ratio 1.33
Return on Assets (%) 10.29
Return on Capital (%) 12.94
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 9.98
Total Assets 192.29
Total Liabilities 192.29
Total Equity 123.14
Share Outstanding 5729666
Price to Book Ratio 0.66
Return on Assets (%) 13.67
Return on Capital (%) 21.23
Particulars MAR 2024 (Values in Cr)
Net Income 18.72
Cash from Operations 4.75
Cash from Investing -104.78
Cash from Financing 110.42
Net change in Cash 0.93
Free Cash Flow 109.05
Particulars MAR 2023 (Values in Cr)
Net Income 23.54
Cash from Operations 30.45
Cash from Investing -77.81
Cash from Financing 60.59
Net change in Cash 4.44
Free Cash Flow 122.05
Particulars MAR 2022 (Values in Cr)
Net Income 27.87
Cash from Operations 4.60
Cash from Investing -6.63
Cash from Financing 9.42
Net change in Cash 1.72
Free Cash Flow 43.55
Particulars MAR 2021 (Values in Cr)
Net Income 27.12
Cash from Operations 31.12
Cash from Investing -43.37
Cash from Financing 10.49
Net change in Cash -8.42
Free Cash Flow 31.96
Particulars MAR 2020 (Values in Cr)
Net Income 32.79
Cash from Operations 24.49
Cash from Investing -12.60
Cash from Financing -2.81
Net change in Cash -0.96
Free Cash Flow 39.50
Particulars MAR 2024 (Values in Cr)
Net Income 30.80
Cash from Operations -13.41
Cash from Investing -16.09
Cash from Financing 34.17
Net change in Cash -4.84
Free Cash Flow -3.05
Particulars MAR 2023 (Values in Cr)
Net Income 32.16
Cash from Operations -2.77
Cash from Investing -13.94
Cash from Financing 28.52
Net change in Cash 3.01
Free Cash Flow 2.28
Particulars MAR 2022 (Values in Cr)
Net Income 28.36
Cash from Operations -16.40
Cash from Investing 21.75
Cash from Financing 2.24
Net change in Cash 1.92
Free Cash Flow -11.64
Particulars MAR 2021 (Values in Cr)
Net Income 27.01
Cash from Operations 28.55
Cash from Investing -40.70
Cash from Financing 10.54
Net change in Cash -8.28
Free Cash Flow 28.55
Particulars MAR 2020 (Values in Cr)
Net Income 34.95
Cash from Operations 24.52
Cash from Investing -12.60
Cash from Financing -3.06
Net change in Cash -1.18
Free Cash Flow 39.53
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

Bharat Parenterals Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
940.90 -1.88 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 957.10
  • 26 Days 985.90
  • 10 Days 966.40
  • 50 Days 1039.20
  • 12 Days 969.20
  • 100 Days 1160.20
  • 20 Days 978.00
  • 200 Days 1244.50
975.50 PIVOT

First Support

942.50

First Resistance

992.00

Second Support

926.00

Second Resistance

1025.00

Third Support

893.00

Third Resistance

1041.50

RSI

40.45

ADX

18.00

MACD

-16.76

Williams % R

-70.94

Commodity Channel Index (CCI)

-176.23

Date

2025-04-30

Week

724.00

Same Day

22.00

Month

772.00

1 Year

0.54

3 Year

0.54

Over 1 Month

-6.61%

down

Over 1 Year

-44.70%

down

Over 3 Months

-27.67%

down

Over 3 Years

38.63%

down

Over 6 Months

-35.09%

down

Over 5 Years

35.76%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Bharat Parenterals Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
32.15%
Promoter Holdings
67.19%
FII
0.1%
DII
0.54%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Desai Shares And Stock Private Limited 2731536.0 (39.63%) Shareholding of Promoter and Promoter Group
Himaben Bharatbhai Desai 962499.0 (13.97%) Shareholding of Promoter and Promoter Group
Bharatkumar Rameshchandra Desai 741655.0 (10.76%) Shareholding of Promoter and Promoter Group
Asoj Soft Caps Pvtltd(anchor) 340130.0 (4.94%) Public Shareholding
Ashish Kacholia 129018.0 (1.87%) Public Shareholding
Madhulika Agarwal 129018.0 (1.87%) Public Shareholding
Sohini Girish Patel 97500.0 (1.41%) Public Shareholding
Manohar Devabhaktuni 94265.0 (1.37%) Public Shareholding
Bhahim Bhartkumar Desai 90281.0 (1.31%) Shareholding of Promoter and Promoter Group
Nikita Bhahim Desai 84267.0 (1.22%) Shareholding of Promoter and Promoter Group
Rajasthan Global Securities Private Limi 78525.0 (1.14%) Public Shareholding
Setu Securities Private Limited 70182.0 (1.02%) Public Shareholding
Varenyam Healthcare Private Limited 16261.0 (0.24%) Shareholding of Promoter and Promoter Group
Shailesh Govindlal Desai 2580.0 (0.04%) Shareholding of Promoter and Promoter Group
Lataben Shaileshkumar Parikh 1479.0 (0.02%) Shareholding of Promoter and Promoter Group
Pooja P Shah 500.0 (0.01%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Bharat Parenterals Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
25 Sep 2023 0.75 Final 25 Sep 2023 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Bharat Parenterals Limited Share Price

Bharat Parenterals Ltd. was incorporated on Sep.'92 in Gujarat and promoted by Ramesh Desai and Bharat Desai. The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda. It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics.

In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company effective 09 July, 2016. Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020. Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective 28th June, 2022.

Parent organization Indian Private
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Bharat Parenterals Ltd?

Answer Field

The share price of Bharat Parenterals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 940.90.

What is the Market Cap of Bharat Parenterals Ltd?

Answer Field

The market cap of Bharat Parenterals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 6,48.50 Cr. as of now.

What is the 52 Week High and Low of Bharat Parenterals Ltd?

Answer Field

The 52 Week High and Low of Bharat Parenterals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1870.00 and ₹ 802.00.

How to Buy Bharat Parenterals Ltd share?

Answer Field

You can trade in Bharat Parenterals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Bharat Parenterals Ltd?

Answer Field

The 1 year returns on the stock has been -44.70%.

What is the Current Share Price of Bharat Parenterals Ltd?

Answer Field

Bharat Parenterals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 940.90 as on Apr 30 2025 03:28 PM.

What is the Market Cap of Bharat Parenterals Ltd Share?

Answer Field

The market cap of Bharat Parenterals Ltd for NSE ₹ 0.0 & for BSE ₹ 6,48.50 as on Apr 30 2025 03:28 PM.

What is the P/E Ratio of Bharat Parenterals Ltd Share?

Answer Field

As on Apr 30 2025 03:28 PM the price-to-earnings (PE) ratio for Bharat Parenterals Ltd share is 23.81.

What is the PB ratio of Bharat Parenterals Ltd Share?

Answer Field

As on Apr 30 2025 03:28 PM, the price-to-book (PB) ratio for Bharat Parenterals Ltd share is 548.29.

How to Buy Bharat Parenterals Ltd Share?

Answer Field

You can trade in Bharat Parenterals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bharat Parenterals Ltd Share on Bajaj Broking App?

Answer Field

To buy Bharat Parenterals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bharat Parenterals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|